No insider purchases or sales are on record for Sunshine Biopharma Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-09-06.
Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | $36.3M | $34.9M | $24.1M | $4.3M |
| GROSS PROFIT | $12.3M | $10.7M | $8.3M | $1.7M |
| OPERATING INCOME | $-6.2M | $-5.8M | $-4.8M | $-27.0M |
| NET INCOME | $-6.0M | $-5.1M | $-4.5M | $-26.7M |
| EPS (DILUTED) | — | -7.32 | -351.36 | -1.76 |
| OPERATING CASH FLOW | $-5.3M | $-12.5M | $-8.8M | $-5.2M |
| CASH | — | — | — | $21.8M |
| BUYBACKS | $0 | $3.1M | $541.1K | — |
No password to create and no card required. We store your email address and nothing else.